Palliative therapy for osteosarcoma

Costantino Errani, Alessandra Longhi, Giuseppe Rossi, Eugenio Rimondi, Alessio Biazzo, Angelo Toscano, Nikolin Alì, Pietro Ruggieri, Marco Alberghini, Piero Picci, Gaetano Bacci, Mario Mercuri

Research output: Contribution to journalArticle

Abstract

Despite advances in diagnostic imaging, the evolution of neoadjuvant chemotherapy and the refinements in limb-salvage surgery, the progression-free survival rate remains poor for patients with metastatic, recurrent or unresectable osteosaroma. Different therapeutic strategies for these subgroups of patients have been employed to control disease and prolong survival. Treatment options are limited and controversial, including systemic and localized therapies. Surgical resection, whenever feasible, is still the standard treatment in advanced osteosarcoma. The role of chemotherapy is unclear while the use of radiotherapy, embolization and thermal ablation is increasing. New therapeutic experimental approaches and novel target therapies are needed to improve the outcome of these subgroups of patients.

Original languageEnglish
Pages (from-to)217-227
Number of pages11
JournalExpert Review of Anticancer Therapy
Volume11
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Osteosarcoma
Palliative Care
Therapeutics
Drug Therapy
Limb Salvage
Diagnostic Imaging
Disease-Free Survival
Radiotherapy
Survival Rate
Hot Temperature
Survival

Keywords

  • bone tumors
  • chemotherapy
  • embolization
  • osteosarcoma
  • palliation
  • radiotherapy
  • surgery
  • thermal ablation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Palliative therapy for osteosarcoma. / Errani, Costantino; Longhi, Alessandra; Rossi, Giuseppe; Rimondi, Eugenio; Biazzo, Alessio; Toscano, Angelo; Alì, Nikolin; Ruggieri, Pietro; Alberghini, Marco; Picci, Piero; Bacci, Gaetano; Mercuri, Mario.

In: Expert Review of Anticancer Therapy, Vol. 11, No. 2, 02.2011, p. 217-227.

Research output: Contribution to journalArticle

Errani, C, Longhi, A, Rossi, G, Rimondi, E, Biazzo, A, Toscano, A, Alì, N, Ruggieri, P, Alberghini, M, Picci, P, Bacci, G & Mercuri, M 2011, 'Palliative therapy for osteosarcoma', Expert Review of Anticancer Therapy, vol. 11, no. 2, pp. 217-227. https://doi.org/10.1586/era.10.172
Errani, Costantino ; Longhi, Alessandra ; Rossi, Giuseppe ; Rimondi, Eugenio ; Biazzo, Alessio ; Toscano, Angelo ; Alì, Nikolin ; Ruggieri, Pietro ; Alberghini, Marco ; Picci, Piero ; Bacci, Gaetano ; Mercuri, Mario. / Palliative therapy for osteosarcoma. In: Expert Review of Anticancer Therapy. 2011 ; Vol. 11, No. 2. pp. 217-227.
@article{721ab3d670644151814c28c90081ec24,
title = "Palliative therapy for osteosarcoma",
abstract = "Despite advances in diagnostic imaging, the evolution of neoadjuvant chemotherapy and the refinements in limb-salvage surgery, the progression-free survival rate remains poor for patients with metastatic, recurrent or unresectable osteosaroma. Different therapeutic strategies for these subgroups of patients have been employed to control disease and prolong survival. Treatment options are limited and controversial, including systemic and localized therapies. Surgical resection, whenever feasible, is still the standard treatment in advanced osteosarcoma. The role of chemotherapy is unclear while the use of radiotherapy, embolization and thermal ablation is increasing. New therapeutic experimental approaches and novel target therapies are needed to improve the outcome of these subgroups of patients.",
keywords = "bone tumors, chemotherapy, embolization, osteosarcoma, palliation, radiotherapy, surgery, thermal ablation",
author = "Costantino Errani and Alessandra Longhi and Giuseppe Rossi and Eugenio Rimondi and Alessio Biazzo and Angelo Toscano and Nikolin Al{\`i} and Pietro Ruggieri and Marco Alberghini and Piero Picci and Gaetano Bacci and Mario Mercuri",
year = "2011",
month = "2",
doi = "10.1586/era.10.172",
language = "English",
volume = "11",
pages = "217--227",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Palliative therapy for osteosarcoma

AU - Errani, Costantino

AU - Longhi, Alessandra

AU - Rossi, Giuseppe

AU - Rimondi, Eugenio

AU - Biazzo, Alessio

AU - Toscano, Angelo

AU - Alì, Nikolin

AU - Ruggieri, Pietro

AU - Alberghini, Marco

AU - Picci, Piero

AU - Bacci, Gaetano

AU - Mercuri, Mario

PY - 2011/2

Y1 - 2011/2

N2 - Despite advances in diagnostic imaging, the evolution of neoadjuvant chemotherapy and the refinements in limb-salvage surgery, the progression-free survival rate remains poor for patients with metastatic, recurrent or unresectable osteosaroma. Different therapeutic strategies for these subgroups of patients have been employed to control disease and prolong survival. Treatment options are limited and controversial, including systemic and localized therapies. Surgical resection, whenever feasible, is still the standard treatment in advanced osteosarcoma. The role of chemotherapy is unclear while the use of radiotherapy, embolization and thermal ablation is increasing. New therapeutic experimental approaches and novel target therapies are needed to improve the outcome of these subgroups of patients.

AB - Despite advances in diagnostic imaging, the evolution of neoadjuvant chemotherapy and the refinements in limb-salvage surgery, the progression-free survival rate remains poor for patients with metastatic, recurrent or unresectable osteosaroma. Different therapeutic strategies for these subgroups of patients have been employed to control disease and prolong survival. Treatment options are limited and controversial, including systemic and localized therapies. Surgical resection, whenever feasible, is still the standard treatment in advanced osteosarcoma. The role of chemotherapy is unclear while the use of radiotherapy, embolization and thermal ablation is increasing. New therapeutic experimental approaches and novel target therapies are needed to improve the outcome of these subgroups of patients.

KW - bone tumors

KW - chemotherapy

KW - embolization

KW - osteosarcoma

KW - palliation

KW - radiotherapy

KW - surgery

KW - thermal ablation

UR - http://www.scopus.com/inward/record.url?scp=79952165556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952165556&partnerID=8YFLogxK

U2 - 10.1586/era.10.172

DO - 10.1586/era.10.172

M3 - Article

C2 - 21342041

AN - SCOPUS:79952165556

VL - 11

SP - 217

EP - 227

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 2

ER -